Page last updated: 2024-09-03

astragaloside a and Cardiac Diseases

astragaloside a has been researched along with Cardiac Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Chen, X; Dai, X; Meng, R; Qin, Y; Shen, C; Tian, C; Wei, X; Zhang, J; Zhang, Z; Zhong, Y1
Hu, X; Li, W; Song, Y; Sun, X; Tang, F; Wang, H; Wang, Q; Xie, X; Yang, X; Zhang, L; Zhao, N; Zhuang, R1
Guo, LH; Huang, X; Liu, B; Ma, SY; Yin, X; Zhang, MZ1
Jiang, TM; Li, YM; Lu, J; Wang, Y; Zeng, S; Zhao, P1

Other Studies

4 other study(ies) available for astragaloside a and Cardiac Diseases

ArticleYear
Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction.
    Frontiers in bioscience (Landmark edition), 2023, 03-03, Volume: 28, Issue:3

    Topics: Doxorubicin; Heart Diseases; Heme Oxygenase-1; Humans; Inflammasomes; Interleukin-18; Myocytes, Cardiac; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pyroptosis; Signal Transduction

2023
Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy.
    Life sciences, 2021, Jun-15, Volume: 275

    Topics: Animals; Apoptosis; Autophagy; Cardiotonic Agents; Echocardiography; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Heart; Heart Diseases; Lipopolysaccharides; Male; MicroRNAs; Microscopy, Electron, Transmission; Myocardium; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes

2021
Astragaloside IV Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction in Rats via IKK/NF-κB Pathway.
    Chinese journal of integrative medicine, 2021, Volume: 27, Issue:11

    Topics: Animals; Disease Models, Animal; Heart Diseases; NF-kappa B; Rats; Rats, Sprague-Dawley; Saponins; Sepsis; Triterpenes; Tumor Necrosis Factor-alpha

2021
Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice.
    Immunopharmacology and immunotoxicology, 2015, Volume: 37, Issue:5

    Topics: Animals; Cytokines; Heart Diseases; Inflammation; Lipopolysaccharides; Mice; Myocardium; Oncogene Protein v-akt; Saponins; Signal Transduction; Transcription Factor RelA; Triterpenes

2015